What a great presentation Dr. Atul Butte gave today during the Innovation Interchange session yesterday afternoon. The main message was that big data in biomedicine means hope!
AMCP’s CEO Edith Rosato opened up the session with a review of our Strategic Priorities – progress in 2013 to date and plans for 2014 – and AMCP’s President Kim Caldwell then introduced the P&T Competition winners for this year (BTW, congratulations to the team from UC-San Francisco).
Dr. Butte took the stage shortly thereafter and gave a really eye-opening presentation about the power of data and data-sharing in medical research – specifically, how this research can help us not just predict future illnesses in patients, but provide cures and preventive measures to keep us healthy.
Finally, his message also hit on the fact that genome and DNA research could hold the key in helping control and lower health care costs.
On another note, there was great news coming from AMCP during this week at Nexus. AMCP announced the establishment of a Biosimilars Task Force to begin developing a Biosimilars Collective Intelligence System to document their safety and efficacy. Using expertise from data consortiums, government, and leading managed care organizations, the proposed initiative would use continuous analysis of available data for innovator specialty drugs as reference points. Make sure to check out our Website at www.amcp.org to read the full release.
Well, there is one more day left here in San Antonio and it’s been amazing to see all of the hard work put into the conference over the past six months come together into a truly fantastic new event!